Safety of immunotherapy side effects and restarting treatment
Part of Cancer, Immune system & allergy clinical trials.
This study looks at patients who had side effects from cancer immunotherapy (checkpoint inhibitors). The goal is to understand those side effects and whether it is safe to restart immunotherapy after they resolve.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older with a cancer diagnosis.
- You received treatment with a type of immunotherapy called a checkpoint inhibitor (such as drugs targeting PD-1, PD-L1, or CTLA-4).
- You had side effects from that immunotherapy that your doctor confirmed as immune-related.
- Your medical records have enough information for researchers to review your side effects and outcomes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at side effects from immune checkpoint inhibitors in people with solid tumors. It aims to understand why side effects happen and who might be at risk, so doctors can better manage them.
This study looks for biological signals (biomarkers) that might predict who will experience side effects from immune checkpoint inhibitor cancer treatments. By understanding these signals early, doctors may be able to better manage or prevent serious immune-related complications.
This trial aims to improve how doctors spot and track side effects from immunotherapy. If you are on or have had immunotherapy, your experience can help build a better system for monitoring these treatments.
This study looks at how immune-related side effects happen in people treated with certain cancer immunotherapies. It also includes some healthy volunteers and people who already have similar autoimmune conditions, to better understand and compare these reactions.
This study tries to predict who is more likely to get serious side effects from immune checkpoint medicines used for solid tumors. You may help researchers by answering questionnaires before treatment and during follow-up, and by possibly storing sample specimens.
This study collects information and biological samples from people who have had significant side effects after immunotherapy for cancer. It aims to understand why these side effects happen and how to improve care for patients in the future.
Hear when a new Immune-Related Adverse Events trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.